Loading
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Latest filing published 09 Sept 2019 for PROGENICS PHARMACEUTICALS INC, €182k.
Filing timeline
BuySaleLTE Partners, LLC
Insider track record
Disclosed buys
2
Disclosed sells
0
Signal history
Closed purchases
Market purchases
2
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
LTE Partners, LLC: trading record in brief
All filings by LTE Partners, LLC on record concern Progenics Pharmaceuticals Inc. Over a trading history stretching from 5 September 2019 to 9 September 2019, the count stands at 2 filings.
Purchases make up the whole of the open-market record (2 purchases, €278k). A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant.
On 9 September 2019 came the latest disclosure, an open-market purchase for €182k in Progenics Pharmaceuticals Inc. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to LTE Partners, LLC
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
43,520 shares@ US$4.620865.5% of flowCommon Stock, $0.0013 par valueSEC:0000921895-19-002384:0
Canonical exit: 4 Dec 2019 (T+90)
21,480 shares@ US$4.939334.5% of flowCommon Stock, $0.0013 par valueSEC:0000921895-19-002384:1
Canonical exit: 8 Dec 2019 (T+90)
2 of 2 declarations
